Ingevity Corp (NGVT)
Ingevity Corp (NGVT) from its SEC filings: 2025 revenue $1.2 billion (-3% vs the year before), net margin -14%, free cash flow $331.2 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Chemicals & Allied Products |
| Revenue (2025) | $1.2 billion |
| Revenue growth | -3% |
| Net income | -$167.1 million |
| Net margin | -14.3% |
| Free cash flow | $331.2 million |
| Diluted EPS | $-4.61 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -5% |
| Cash | $97.4 million |
| Share count, 1 year | -6% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.